Vijaya Diagnostic Centre Reports 37.6% PAT Growth in Q1 FY27

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Vijaya Diagnostic Centre Reports 37.6% PAT Growth in Q1 FY27

Vijaya Diagnostic Centre reported a 37.6% year-on-year rise in Profit After Tax (PAT) to ₹53.1 crore for Q1 FY27. Revenue also grew 22.8% to ₹231 crore, with EBITDA up 34.0%. The company is expanding its network and integrating AI tools.

Vijaya Diagnostic Centre Sees Strong Q1 FY27 Performance

Revenue from operations stood at ₹231 crore, a 22.8% increase year-on-year.
Profit After Tax (PAT) grew by 37.6% to ₹53.1 crore.

Reader Takeaway: Strong revenue and profit growth driven by network expansion and technology adoption, with margin expansion.

What just happened

Vijaya Diagnostic Centre announced its financial results for the first quarter of FY27 (ending June 30, 2026). The company reported a significant 22.8% year-on-year increase in revenue from operations, reaching ₹231 crore. Profit After Tax (PAT) saw a substantial jump of 37.6%, amounting to ₹53.1 crore. EBITDA also rose by 34.0% to ₹98.5 crore.

Why this matters

These results indicate robust operational execution and effective cost management. The strong growth in both top-line (revenue) and bottom-line (PAT) suggests that the company's business model is scaling effectively. Improved margins, with EBITDA margin at 42.7% and PAT margin at 23.0%, highlight enhanced profitability and operational efficiency.

The backstory

The company operates a network of 166 centres as of June 30, 2026. Recent strategic moves include commissioning new spokes in Hyderabad, Andhra Pradesh, and Pune, and launching flagship hubs in Bengaluru and Hyderabad. Vijaya Diagnostic is also integrating advanced AI tools for radiology and other diagnostic areas, alongside focusing on its wellness segment.

What changes now

Vijaya Diagnostic Centre plans further expansion, aiming to commission 9 new hub centres and 10-12 spoke centres in the next 12 months, particularly focusing on East India and its core markets in AP/Telangana. This strategic push aims to increase geographic reach and network densification.

Risks to watch

While the results are positive, investors should monitor the successful integration of new acquisitions and the operational efficiency of newly commissioned centres. Ensuring consistent clinical precision and reporting efficiency with AI integration will also be crucial.

Peer comparison

As a diagnostic services provider, Vijaya Diagnostic operates in a growing market. Competitors include other large diagnostic chains and smaller regional players. The company's focus on technology and margin expansion is key to maintaining its competitive edge.

Context metrics (time-bound)

In Q1 FY27, Vijaya Diagnostic Centre served 1.24 million customers. The wellness segment contributed 14.8% to the revenue in the quarter. The company's network comprises 166 centres, including new hubs launched in Bengaluru and Hyderabad.

What to track next

Investors will be keen to observe the revenue contribution from newer geographies like Pune and Bengaluru, and the profitability of the planned new hub-and-spoke centres. Continued progress in AI integration and its impact on service delivery and cost-effectiveness will also be key performance indicators.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.